Crossref
Study supports weekly buprenorphine during and after pregnancy
Alcoholism & Drug Abuse Weekly · 23.03.2026 · 38 (12) · 6-7
DOI: 10.1002/adaw.34852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcoholism & Drug Abuse Weekly, online erschienen am 20.03.2026. Verfasst von Alison Knopf.
Abstract (Originalsprache)
A landmark study supporting weekly extended‐release buprenorphine for opioid use disorder (OUD) treatment during pregnancy was published in JAMA Internal Medicine online March 16.
Zitieren
APA
Knopf, A. (2026). Study supports weekly buprenorphine during and after pregnancy. Alcoholism & Drug Abuse Weekly, 38(12), 6-7. https://doi.org/10.1002/adaw.34852
Vancouver
Knopf A. Study supports weekly buprenorphine during and after pregnancy. Alcoholism & Drug Abuse Weekly. 2026;38(12):6-7. doi:10.1002/adaw.34852
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {Study supports weekly buprenorphine during and after pregnancy},
journal = {Alcoholism & Drug Abuse Weekly},
year = {2026},
volume = {38},
number = {12},
pages = {6--7},
doi = {10.1002/adaw.34852}
}
EUVIMED